chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills - the day after the 1st vaccine shot; Fatigue- the evening of the 1st vaccine shot and through the following day; General feeling of not feeling well; This is a spontaneous report from a contactable consumer.  A 67-years-old female patient (not pregnant at the time of vaccination) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 07mar2021 16:00 as single dose for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's medical history was not reported.The patient had hypersensitivity (Environmental/seasonal; e.g. dust, mold, trees, grass, cats, dogs). The Concomitant medication's included multivitamins and minerals taken for an unspecified indication, start and stop date were not reported. On 07Mar2021 at 04:30 PM, the patient experienced fatigue at the evening of the 1st vaccine shot and the next day the patient has general feeling of not feeling well and chills. Since after the vaccination, the patient was not tested for COVID-19. No treatment was received for the adverse events. The outcome of the events were recovered.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Got Tdap on 8/28/12 at 2pm reaction started 8/29/12 am redness - itching - warm to touch - dizzy - fever measured reaction at 3 x 2 1/4. Pt. was told could take BENADRYL/cool compress.
Received Moderna COVID-19 Vaccine EUA - one day later had redness, swelling and pain circling about 1 inch around the injection site.
35 hours post vaccination, pt sitting at kitchen table, after a nap, felt week and vision began to narrow and become black and tunnelled, pt could not get her words out then fell out of the chair, hitting her forehead on flood.  hands and legs were shaking and pt felt like she couldn't breathe.  total event time 5 minutes without loc.  within 5 minutes of shaking stopping, EMS has arrived and pt was or normal cognitiion and awareness.  pt was taken to ER for evaluation, and their eval was that pt has a seizure. Per my collection of hx of event, pt had no postictal period.  pt was not prescribed any antiepileptics and was only given verbal precautions to follow regarding future seizures.  Pt on exam today (18 hours a 18 hours post event) had completely nml exam including complete neuro exam.  peds neurology referral ordered
RESTLESS LEG SYNDROME ON THE RIGHT LEG; SLEEPY; TIRED; BODY ACHES; FEVER; This spontaneous report received from a patient concerned a 35 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient denies having a history of restless leg syndrome. patient had 1 to 2 brief instances years ago. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, and expiry: 25-MAY-2021) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 16-MAR-2021, the subject experienced body aches. On 16-MAR-2021, the subject experienced fever. On 18-MAR-2021, the subject experienced restless leg syndrome on the right leg. On 18-MAR-2021, the subject experienced sleepy. On 18-MAR-2021, the subject experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from restless leg syndrome on the right leg on 18-MAR-2021, and body aches, and fever on 16-MAR-2021, and had not recovered from sleepy, and tired. This report was non-serious.; Sender's Comments: Medical assessment comment not required as per standard operating procedure, as the case is assessed as Non-serious.
Chills, Body Ache, Headache, Dizziness,  Pain in Arm of Injection and Fatigue   Body Ache, Pain and Fatigue set in about 8 to 9 hours after Injection. Headache followed. The next day body ache and Fatigue persisted. Dizziness onset late on the second day of symptoms and still persists.
TORN ROTATOR CUFF; SHOULDER PAIN (FEEL COMING FROM ARMPIT, SHOULDER SOCKET AND SHOULDER NUMBNESS ON SKIN, PAIN GOING ALL THE WAY THROUGH SHOULDER JOINTS, PAIN RADIATING DOWN IN ARM AND IN WRIST AND HAND); BLED MORE THAN USUAL; This spontaneous report received from a patient concerned a 66 year old male. The patient's height, and weight were not reported. The patient's past medical history included shoulder injury. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1802070, expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 to right deltoid for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced bled more than usual. On 16-MAR-2021, the subject experienced shoulder pain (feel coming from armpit, shoulder socket and shoulder numbness on skin, pain going all the way through shoulder joints, pain radiating down in arm and in wrist and hand). On an unspecified date, the subject experienced torn rotator cuff. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from shoulder pain (feel coming from armpit, shoulder socket and shoulder numbness on skin, pain going all the way through shoulder joints, pain radiating down in arm and in wrist and hand), and the outcome of torn rotator cuff and bled more than usual was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case assessed as non serious.
She received her Johnson and Johnson vaccination last April in her left arm. She waited the required 15 minutes without complication. However, upon driving home, approximately 30 minutes after her vaccine she developed left arm and facial numbness and felt as if her tongue was swelling. She monitored her symptoms at home, no further complications or symptoms developed but since that time she has had the numbness in her face and arm.  Alert & oriented. Gait WNL. Strength, circulation and sensation intact right arm, B/L LE. Intact strength 5/5 and circulation to left upper arm. Full ROM of left shoulder, elbow, wrist and fingers when compared to right.  Full sensation to left arm from elbow to fingertips.  Numbness and mild - moderate loss of sensation from left shoulder to elbow.  Numbness and decreased sensation to left face, isolated to left cheek, not extending beyond the boarder of the chin, nose, lips or eyes. ,Alert & oriented.
Client states extreme swelling of both knees 13 d after vaccine. Very runny nose on day 12, lasting approximately 24 hr. Day 13, both wrists and ankles very stiff, "wouldn't bend". Above problems lasted -  approximately 48 hours. By day 16, problems had mostly resolved except for residual stiffness of joints which still continues.
vaccine was pulled up in the syringe on 08NOV2021 and stored in room temperature for 23 hours prior to administering; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERERED in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021 at 11:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine was pulled up in the syringe on 08NOV2021 and stored in room temperature for 23 hours prior to administering). On 09-Nov-2021, EXPIRED PRODUCT ADMINISTERED had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. List of concomitant medication were not given. The vial that was first punctured on 08NOV2021 at noon. The vaccine was pulled up in the syringe on 08NOV2021 and stored in room temperature for 23 hours prior to administering a half dose booster to a patient
Information has been received from a registered nurse who reported that many years ago she was doing auditing and she saw that one boy came in to the nurses' office. It was reported that there was on boy that was unrelated, not in the same classes or lunch, with different physicians. The boy on unspecified dates, had received two doses of VARIVAX (Merck) and had a mild chicken pox outbreak on neck. The registered nurse contacted during telephone follow-up could not supply the following information: patient's name, dates of birth, dates of vaccination, lot numbers, dates of the events, recovery status, health care provider name and contact information. The registered nurse contacted during telephone follow-up could not supply the following information: patient's name, dates of birth, dates of vaccination, lot numbers, dates of events, recovery status, health care provider name and contact information. This is one of several reports received from the same source. Additional information is not expected.
Within 24 hours - fever, headache, cough, chills lethargy, body aches - lasting 7 days.
This case was reported by a other health professional and described the occurrence of inappropriate age at vaccine administration in a 29-month-old male patient who received FLUARIX QUADRIVALENT, the patient experienced inappropriate age at vaccine administration and wrong administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. It was unknown if the reporter considered the inappropriate age at vaccine administration and wrong vaccine administered to be related to FLUARIX QUADRIVALENT. Additional information received on 26 September 2014: FLUARIX QIV was administered instead of another flu vaccine approved for that age.
Rash on face, 8/22/99. Seen at Med Ctr, 8/23/99, had fever 103.8; seen at Health Dept, 8/25/99. Pt presented with macular papular rash on face, neck, back, chest & arms. Axillary temp 98.2. Rash extremely erythemic.
metallic smell in mouth and nose; a raw meat taste and smell; a raw meat taste and smell; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient believed they are having a side effect from the Pfizer covid vaccine; a raw meat taste and smell, a metallic smell in mouth and nose which has gotten progressively worse. It started Saturday at 1 o clock. Every time their nose drains it taste like raw meat down the back of their throat. The patient would like to know how long their side effects from the covid vaccine would last. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient received expired Moderna vaccine from previous day, the vial was left out in room temperature ~24 hours from first punctured.  A technician who prepared the dose didn't realize that the bottle was used and lukewarm. Notified the patient as as soon as we noticed it and apologized gave replacing dose per CDC recommendations.
RD remained sore for at least one month after vaccine administration. Right arm is sore, she cannot lay on the right side, and she cannot raise her right arm all the way.
%Patient presented to Hospital on 11/24/2021 with SOB.  Per EMS, patient was 78% on room air, and placed the patient on 6LNC, and came up to 94%.  CT of  thorax  impression: negative for PE, airways of the LLL associated segmental atelectasis, severe emphysema, multiple stable chronic compression fractures of thoracic spine, atherosclerosis including coronary arterial calcifications.  CXR impression: cardiomegaly with suspected mild pulmonary edema superimposed on chronic interstitial changes.  Hospital course was complicated by decreasing oxygenation and increasing pulmonary hypoxemia.  She required BiPAP and eventually intubation.  Family requested she be extubated on 12/08/2021 and expired shortly after.
felt like she was going to die; got really sick, a mess; can't breathe; chills but no fever; body really sore; head hurt every day; nose running really really bad but at first it was dry; This is a spontaneous report from a contactable consumer (patient).  A 44-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 01Apr2021 at single dose in left arm for COVID-19 immunisation at the age of 44-year-old. Lot number was ER8733. Medical history included diabetes, Covid-19 in 2020. Concomitant medications included metformin for diabetes from 2019 and ongoing, insulin lispro (HUMALOG) for diabetes from 2019 and ongoing, insulin detemir (LEVEMIR) for diabetes from 2019 and ongoing. On 13Apr2021, patient felt like she was going to die, she could not breath. On 06Apr2021, the patient experienced got really sick, a mess, could not breath, chills but no fever, body really sore, head hurt every day, nose running really bad but at first it was dry. Since then, the patient has been very sick, like really sick, could not even be out of bed until the day before the report and the day of report she felt a little bit better. The patient has been drinking a lot of lemon juice; she also has been taking guaifenesin chest and runny nose congestion, guaifenesin Sinus Extra and acetaminophen. The husband of the patient got sick on Thursday or Friday; it was raining he got wet, so he was coughing; they have 3 kids, and the little one got sick same day as her. The patient did not recover from headache; the outcome of felt like she was going to die was unknown; the patient was recovering from other events. Patient stated that she was not saying it was because of the shot, but it was really confusing, she might get sick because her husband got sick for a few days and was outside working and it was raining and really really cold.
PATIENT PRESENTED WITH AN ABNORMAL RAPID HEART BEAT (TACHYCARDIA) WAS TAKEN BY AMBULANCE TO THE NEAR CDT.
Information has been received from a registered nurse concerning an approximately 27 year old male consumer with no known allergies or pertinent medical history who in 1978 was vaccinated with one dose of MMR II. In 2004, medical attention was sought, the patient was seen in the office and a mumps titer was performed. It was reported that the patient had a negative titer for mumps. At the time of the report the patient had not recovered. There was no product quality complaint involved. Additional information has been requested.
No additional adverse effects reported; Improperly stored ROTATEQ administered to patient on 14-FEB-2020; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs, drug reactions and allergies was not provided.  On 14-FEB-2020, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally, lot # S005878, expiration date on 25-DEC-2020 (dose was not provided) for prophylaxis. The vaccine was exposed to a temperature above 47 degree fahrenheit/ 9 degree celsius (46.84F) during 15 minutes. It was reported that digital data logger was involved. There was not previous temperature excursion. No adverse effects were reported.
Acute aortic thrombus that extended to the left renal artery with occlusion of the left renal artery. I had an aortic thrombectomy at local medical center. I went to the ER with left flank pain at which time a ct scan was done and the clot was found.
Patient states that one week after receiving vaccine, she broke out in a rash on her arms, torso, and legs.
Began feeling feverish and chills around 10:00pm Oct 29. Woke up around 1:00am Oct 30 feeling nauseous, vomited seven times between 1-7am. Sore throat following first retching and appeared to be blood in the first vomit. Spent Oct 30-31 fatigued and sore.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated in the pharmacy with PNEUMOVAX 23 (lot # J007786, expiration date: 25-SEP-2014). Route of administration and dose were not reported. Concomitant medications were not reported. On 29-SEP-2013 the patient experienced serious swelling at the injection site and complained of pain. These injection site reactions were larger than the pharmacy has ever seen before. The patient sought for medical attention and treatment was given for the events (not specified). The outcome of the adverse events was reported as recovering. The relationship between PNEUMOVAX and the adverse events was not reported. The pharmacist stated there have been 5 or 7 patients who have received this Lot and have not reported any reactions. A lot check was requested by pharmacist. This case is linked to case 1310USA003793 and 1310USA003792 via same reporter link. Additional information has been requested.
Administerd vaccine that was not stored in recommended temprature; A report was received from a health care professional concerning a 39-year old patient participating in the mRNA-1273 Emergency Use Program who was administered vaccine that was not stored in recommended temperature.  The patient's medical history was not provided. No relevant concomitant medications were reported.   The patient received their first of two planned doses of mRNA-1273 (Lot 011J20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection on 21 Dec 2020. On the same day, the nurse noticed administered vaccine was not stored in recommended temperature. Temperature reading of -21.6 and -20.9 ranges were in Fahrenheit instead of Celsius as the freezer reading was set to Fahrenheit. The nurse called to inquire whether the vaccine is usable. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, administered vaccine that was not stored in recommended temperature, was unknown.   The reporter did not provide an assessment for the event of administered vaccine that was not stored in recommended temperature.; Reporter's Comments: This case concerns a 39-year-old patient who received their first of two planned doses of mRNA-1273 (Lot 011J20A), reporting Product storage error without any associated adverse events.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 56-year-old male patient received BNT162b2 (Pfizer-BioNTech COVID-19), as dose 4, single (Batch/Lot number: unknown) at the age of 55 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing), notes: HTN. Patient had no known allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient received Paxlovid to treatment "drug ineffective" and "covid-19"  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Broke out in hives all over my legs a day and a half after receiving my second dose. Hives are incredibly itchy and calamine lotion does not soothe them. Lasted 12 hours so far.
No further AE  TE Case02454494; Medical Tech calls to report vaccine given during an excursion.  No PQC. No further AE  TE Case02454494; This spontaneous report has been received from a medical tech and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not provided.  On 17-AUG-2023, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live, recombinant human albumin (rha) (PROQUAD) injection, one time (valid lot number W038815 [expiration date 04-JUN-2024]) (dose, dose number, frequency, route of administration vaccination scheme, and anatomical location were not provided), administered for prophylaxis, after a temperature excursion (product storage error).   No further adverse events (AEs) details.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2308USA007402:
Swollen Lympf Nodes(7 days), slight headache(two weeks) tiredness(1 week)muscle aches(1 week),severe itching on back (no rash(2 weeks)nausea(1 day)  Tylenol for headache, rest for tiredness, caladryl, Zyrtec, Pepcid for severe itchiness, Dr visit on Feb.22 - had me take a flu/covid test came back negative.
Very bad muscle soreness day after vaccine; Headache; fever; chills; This is a spontaneous report from a non-contactable consumer (Patient). A 23-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot Number: unknown) via an unspecified route of administration in the left arm on 06Apr2021 at 17:00 (at the age of 23-year-old) as dose 2, single for COVID-19 immunization. Medical history included gilbert's syndrome and familial tremor both from an unspecified date an unknown if ongoing. The patient had no allergies to medications, food, or other products. The patient did not receive any concomitant medication within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Historical vaccine included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration in the left arm on 16Mar2021 at 17:30 (at the age of 22-year-old) as dose 1, single for COVID-19 immunization. On 07Apr2021 at 03:00, the patient experienced very bad muscle soreness day after vaccine, headache, fever, and chills. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Outcome of the events were not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.